NeuroSense Therapeutics Ltd (NASDAQ: NRSN) is 59.24% higher on its value in year-to-date trading and has touched a low of $0.51 and a high of $2.33 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NRSN stock was last observed hovering at around $1.36 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $1.25, the stock is 20.01% and 10.87% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.45 million and changing -8.09% at the moment leaves the stock 8.11% off its SMA200. NRSN registered 60.88% gain for a year compared to 6-month gain of 47.75%. The firm has a 50-day simple moving average (SMA 50) of $1.12506 and a 200-day simple moving average (SMA200) of $1.15897.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 35.87% loss in the last 1 month and extending the period to 3 months gives it a 0.00%, and is 41.45% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 23.52% over the week and 15.30% over the month.
NeuroSense Therapeutics Ltd (NRSN) has around 18 employees, a market worth around $28.91M and $0.00M in sales. Distance from 52-week low is 144.14% and -46.35% from its 52-week high.
The EPS is expected to grow by 33.73% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
NeuroSense Therapeutics Ltd (NRSN) Top Institutional Holders
The shares outstanding are 19.81M, and float is at 13.48M with Short Float at 2.41%.
The top institutional shareholder in the company is ARMISTICE CAPITAL, LLC with over 1.58 million shares valued at $1.77 million. The investor’s holdings represent 10.2822% of the NRSN Shares outstanding. As of 2024-06-30, the second largest holder is MEITAV INVESTMENT HOUSE LTD with 40000.0 shares valued at $44800.0 to account for 0.2597 of the shares outstanding. The other top investors are XTX TOPCO LTD which holds 32650.0 shares representing 0.2119% and valued at over $36568.0, while GEODE CAPITAL MANAGEMENT, LLC holds 0.0777 of the shares totaling 11963.0 with a market value of $13398.0.
NeuroSense Therapeutics Ltd (NRSN) Insider Activity
#####
